Shares of our common stock are listed on the NASDAQ OTC market and trade under the symbol “UEEC“.
For more information, please contact investor@uhpcorp.com
For press and media relations, please contact media@uhpcorp.com
Press Releases
-
United Health Products Provides Update on Clinical Study Process
Mount Laurel, New Jersey – December 2, 2024 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s planned clinical study. As previously disclosed, United Health Products is conducting a clinical trial of its CelluSTAT Hemostatic Gauze product (formerly branded as HemoStyp) in response to the FDA’s request for additional clinical…
-
United Health Products Provides Update on FDA PMA Application
Mount Laurel, New Jersey – November 4, 2024 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval (PMA) application process. Following the company’s August 15, 2024 submission of its Submission Issue Request (SIR) to the FDA which responded to certain questions in the FDA’s June 18 letter…
-
United Health Products Submits Response Letter to FDA
Mount Laurel, New Jersey – August 19, 2024 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval (PMA) application process. Following the company’s March 21 submission of its PMA application and the FDA’s June 18 “Deficiencies Letter” to the company listing certain questions and comments on various…
-
United Health Products Provides Update on FDA PMA Application
Mount Laurel, New Jersey – June 24, 2024 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval (PMA) application process. Following the company’s March 21 submission of its PMA application and as part of its substantive review, on June 18 the Food & Drug Administration issued a…